Tumor Ablation Market Growth at CAGR of 12.97%, 2018-2023 - Latest Challenges and Trends – Major key players Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc

Tumor Ablation Market Overview

Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung, and liver. Rising Prevalence of cancer is proportional to the growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.

 

Request for Sample @ https://www.marketdataforecast.com/market-reports/tumor-ablation-market-472/request-sample

Factors such as growing geriatric population across the globe, increasing number of people affected by cancer, technological advancements in the field of ablation are driving the global tumor ablation market. Increasing demand for minimally invasive cancer treatment procedures and growing awareness regarding the benefits offered by ablation procedures over the conventional surgical procedures are also fuelling the growth of the Tumor Ablation market. However therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to increasing in gestation period of product launches are hindering the growth of the market.

 

Tumor Ablation Market Forecast Report (2018-2023)

Tumor Ablation Market was worth USD 0.48 million in 2018 and estimated to be growing at a CAGR of 12.97%, to reach USD 0.88 million by 2023

 

Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/tumor-ablation-market-472/

 

Tumor Ablation Market Segmentation

The market is segmented into technology treatment and application. On the basis of technology, and further sub-segmented as Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices segment dominated the market with a share of about 35% attributed to its crucial role in solid tumor removal in the body. By treatment, the market is segmented as Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation. Surgical Procedures segment accounted for a prominent share of around 37% owing to increasing prevalence of liver and breast cancers. Based on application global tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.

 

On the basis of geography, global Tumor Ablation market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America dominated the industry with over 33% owing to its advanced healthcare infrastructure. Rising prevalence of cancer in this region is a major driving factor for the industry in this region. The Asia Pacific is estimated to be the fastest growing region during the forecast period due to huge population base and favorable economic developments in the region.

 

Buy now @ https://www.marketdataforecast.com/cart/buy-now/tumor-ablation-market-472/

 

Major Players: 

The major companies dominating this market for its products and services are

Medtronic Plc.,
Boston Scientific Corporation,
Angio dynamics,
Mermaid Medical,
HealthTronics,
Galil Medical Inc.,
EDAP TMS S.A.,
SonaCare Medical,
Misonix, Inc.
Neuwave Medical, Inc.
 

Customize Report @ https://www.marketdataforecast.com/market-reports/tumor-ablation-market-472/customize-report

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com

This release was published on openPR.